4-69485380-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021139.3(UGT2B4):c.1138A>G(p.Ile380Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021139.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2B4 | NM_021139.3 | c.1138A>G | p.Ile380Val | missense_variant | 5/6 | ENST00000305107.7 | NP_066962.2 | |
UGT2B4 | NM_001297616.2 | c.730A>G | p.Ile244Val | missense_variant | 6/7 | NP_001284545.1 | ||
UGT2B4 | NM_001297615.2 | c.1090+1229A>G | intron_variant | NP_001284544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT2B4 | ENST00000305107.7 | c.1138A>G | p.Ile380Val | missense_variant | 5/6 | 1 | NM_021139.3 | ENSP00000305221 | P1 | |
UGT2B4 | ENST00000512583.5 | c.1090+1229A>G | intron_variant | 1 | ENSP00000421290 | |||||
UGT2B4 | ENST00000502655.5 | n.1015A>G | non_coding_transcript_exon_variant | 6/6 | 5 | |||||
UGT2B4 | ENST00000506580.5 | n.872+1229A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2021 | The c.1138A>G (p.I380V) alteration is located in exon 5 (coding exon 5) of the UGT2B4 gene. This alteration results from a A to G substitution at nucleotide position 1138, causing the isoleucine (I) at amino acid position 380 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.